Cantos Ventures — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Joshua Yang(Founder & CEO)Daniel Estandian(Founder)Ed Boyden(Founder)Josh Yang(Founder)in
BoardCraig Asher(Director)inJimmy Yun(Director)
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesLongeVCModi Ventures+3 more
Salient Motion designs and manufactures critical actuation systems for commercial aviation and defense applications.
Advanced ManufacturingDefense TechHardwareSouthern California, US
Vishaal Mali(Chief Executive Officer)
Co-investorsBoeing HorizonX VenturesDns CapitalHummingbird VenturesAndreessen HorowitzBoxGroup
Shinkei deploys robotics and computer vision hardware on commercial fishing vessels to process seafood at sea, improving quality and traceability while reducing America's seafood import reliance.
Advanced ManufacturingAgTechAI & Machine LearningFoodTechHardwareRoboticsLos Angeles, US
Saif Khawaja(Founder)in
Co-investorsDorm RoomGlobal BrainHumba VenturesImpatient VenturesMantis CapitalMARKHAM VALLEY VENTURES+10 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.